Genomics of chronic allograft injury

Enver Akalin, Philip J. O'Connell

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Chronic allograft injury (CAI) is common after kidney transplantation in which immunological (e.g., acute and chronic cellular and antibody-mediated rejection) and nonimmunological factors (e.g., donor-related factors, ischemia-reperfusion injury, polyoma virus, hypertension, and calcineurin inhibitor nephrotoxicity) have a role. Despite the new Banff pathological classification, histopathological diagnosis is still far from being the 'gold standard' to understand the exact mechanisms in the development of CAI, which may lead to appropriate treatment. Microarray is a powerful technology that detects thousands of genes simultaneously and might be an important tool in elucidating patterns for mechanism, diagnosis, prognosis, and treatment of complex, multifactorial diseases, such as CAI. In this review, we discuss the studies that applied microarray technology in kidney transplant patients with CAI.

Original languageEnglish (US)
JournalKidney International
Volume78
Issue numberSUPPL. 119
DOIs
StatePublished - Dec 2010

Fingerprint

Genomics
Allografts
Wounds and Injuries
Technology
Polyomavirus
Reperfusion Injury
Kidney Transplantation
Tissue Donors
Hypertension
Transplants
Kidney
Antibodies
Therapeutics
Genes

Keywords

  • Affymetrix
  • chronic rejection
  • GeneChip
  • kidney transplantation
  • microarray

ASJC Scopus subject areas

  • Nephrology

Cite this

Genomics of chronic allograft injury. / Akalin, Enver; O'Connell, Philip J.

In: Kidney International, Vol. 78, No. SUPPL. 119, 12.2010.

Research output: Contribution to journalArticle

Akalin, Enver ; O'Connell, Philip J. / Genomics of chronic allograft injury. In: Kidney International. 2010 ; Vol. 78, No. SUPPL. 119.
@article{7e68b0b0c0b242df84987f3f3196c8dc,
title = "Genomics of chronic allograft injury",
abstract = "Chronic allograft injury (CAI) is common after kidney transplantation in which immunological (e.g., acute and chronic cellular and antibody-mediated rejection) and nonimmunological factors (e.g., donor-related factors, ischemia-reperfusion injury, polyoma virus, hypertension, and calcineurin inhibitor nephrotoxicity) have a role. Despite the new Banff pathological classification, histopathological diagnosis is still far from being the 'gold standard' to understand the exact mechanisms in the development of CAI, which may lead to appropriate treatment. Microarray is a powerful technology that detects thousands of genes simultaneously and might be an important tool in elucidating patterns for mechanism, diagnosis, prognosis, and treatment of complex, multifactorial diseases, such as CAI. In this review, we discuss the studies that applied microarray technology in kidney transplant patients with CAI.",
keywords = "Affymetrix, chronic rejection, GeneChip, kidney transplantation, microarray",
author = "Enver Akalin and O'Connell, {Philip J.}",
year = "2010",
month = "12",
doi = "10.1038/ki.2010.420",
language = "English (US)",
volume = "78",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "SUPPL. 119",

}

TY - JOUR

T1 - Genomics of chronic allograft injury

AU - Akalin, Enver

AU - O'Connell, Philip J.

PY - 2010/12

Y1 - 2010/12

N2 - Chronic allograft injury (CAI) is common after kidney transplantation in which immunological (e.g., acute and chronic cellular and antibody-mediated rejection) and nonimmunological factors (e.g., donor-related factors, ischemia-reperfusion injury, polyoma virus, hypertension, and calcineurin inhibitor nephrotoxicity) have a role. Despite the new Banff pathological classification, histopathological diagnosis is still far from being the 'gold standard' to understand the exact mechanisms in the development of CAI, which may lead to appropriate treatment. Microarray is a powerful technology that detects thousands of genes simultaneously and might be an important tool in elucidating patterns for mechanism, diagnosis, prognosis, and treatment of complex, multifactorial diseases, such as CAI. In this review, we discuss the studies that applied microarray technology in kidney transplant patients with CAI.

AB - Chronic allograft injury (CAI) is common after kidney transplantation in which immunological (e.g., acute and chronic cellular and antibody-mediated rejection) and nonimmunological factors (e.g., donor-related factors, ischemia-reperfusion injury, polyoma virus, hypertension, and calcineurin inhibitor nephrotoxicity) have a role. Despite the new Banff pathological classification, histopathological diagnosis is still far from being the 'gold standard' to understand the exact mechanisms in the development of CAI, which may lead to appropriate treatment. Microarray is a powerful technology that detects thousands of genes simultaneously and might be an important tool in elucidating patterns for mechanism, diagnosis, prognosis, and treatment of complex, multifactorial diseases, such as CAI. In this review, we discuss the studies that applied microarray technology in kidney transplant patients with CAI.

KW - Affymetrix

KW - chronic rejection

KW - GeneChip

KW - kidney transplantation

KW - microarray

UR - http://www.scopus.com/inward/record.url?scp=78649647346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649647346&partnerID=8YFLogxK

U2 - 10.1038/ki.2010.420

DO - 10.1038/ki.2010.420

M3 - Article

VL - 78

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - SUPPL. 119

ER -